Tag: oncology
Molecular Tumor Boards Reduce Death Risk by 13% in Cancer Patients, Meta-Analysis Shows
Comprehensive meta-analysis of 78 studies shows molecular tumor boards reduce cancer death risk by 13% and progression risk by 27%.…
New Biomarkers Could Predict Melanoma Outcomes in High-Risk Patients
Swedish research identifies tumor tissue markers that could predict melanoma outcomes. Study of 6,000+ annual cases shows promise for personalized…
Multi-Cancer Screening Test Fails Primary Endpoint but Reveals Promising Early Detection Signals
World's largest multi-cancer detection trial fails primary mortality endpoint but reveals important early detection capabilities. SUMMIT study with 140,000 participants…
Cancer Spreads More in Middle Age Than in Very Old Age, Melanoma Study Shows
New research reveals that melanoma spreads most in middle-aged mice, not elderly ones as expected. Special immune cells that keep…
Teclistamab Shows Strong Response Rates in Earlier-Line Multiple Myeloma Treatment
Phase 3 trial shows teclistamab extends progression-free survival by 7.3 months compared with standard treatments in multiple myeloma patients with…
DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy
New genetic testing could spare 6,600 UK breast cancer patients annually from unnecessary chemotherapy while maintaining equivalent survival rates. International…
Perioperative Treatment Revolution Could Transform Prostate Cancer Outcomes
New evidence suggests perioperative therapy could fundamentally transform prostate cancer treatment outcomes. The approach challenges traditional sequencing of surgery and…
New Drug Daraxonrasib Nearly Doubles Pancreatic Cancer Survival in Phase 3 Trial
Daraxonrasib nearly doubles survival in advanced pancreatic cancer patients with KRAS G12C mutations. The breakthrough targets a previously "undruggable" protein…